↓ Skip to main content

Preoperative chemotherapy is safe in early breast cancer, even after 10 years of follow-up; clinical and translational results from the EORTC trial 10902

Overview of attention for article published in Breast Cancer Research and Treatment, May 2008
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (85th percentile)
  • High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

policy
3 policy sources

Citations

dimensions_citation
90 Dimensions

Readers on

mendeley
71 Mendeley
Title
Preoperative chemotherapy is safe in early breast cancer, even after 10 years of follow-up; clinical and translational results from the EORTC trial 10902
Published in
Breast Cancer Research and Treatment, May 2008
DOI 10.1007/s10549-008-0050-1
Pubmed ID
Authors

Johanna G. H. van Nes, Hein Putter, Jean-Pierre Julien, Michelle Tubiana-Hulin, Marc van de Vijver, Jan Bogaerts, Monika de Vos, Cornelis J. H. van de Velde, Cooperating Investigators of the EORTC

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 71 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 3%
Japan 1 1%
Korea, Republic of 1 1%
Unknown 67 94%

Demographic breakdown

Readers by professional status Count As %
Researcher 12 17%
Other 10 14%
Student > Ph. D. Student 10 14%
Student > Bachelor 7 10%
Student > Master 6 8%
Other 12 17%
Unknown 14 20%
Readers by discipline Count As %
Medicine and Dentistry 36 51%
Biochemistry, Genetics and Molecular Biology 2 3%
Nursing and Health Professions 2 3%
Pharmacology, Toxicology and Pharmaceutical Science 2 3%
Computer Science 2 3%
Other 7 10%
Unknown 20 28%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 July 2018.
All research outputs
#3,697,942
of 24,920,664 outputs
Outputs from Breast Cancer Research and Treatment
#610
of 4,923 outputs
Outputs of similar age
#11,191
of 93,016 outputs
Outputs of similar age from Breast Cancer Research and Treatment
#1
of 30 outputs
Altmetric has tracked 24,920,664 research outputs across all sources so far. Compared to these this one has done well and is in the 84th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,923 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.3. This one has done well, scoring higher than 86% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 93,016 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 85% of its contemporaries.
We're also able to compare this research output to 30 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.